rs121909490
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001174147.2(LMX1B):c.691C>T(p.Arg231*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001174147.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMX1B | NM_001174147.2 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | ENST00000373474.9 | NP_001167618.1 | |
LMX1B | NM_001174146.2 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | NP_001167617.1 | ||
LMX1B | NM_002316.4 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | NP_002307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMX1B | ENST00000373474.9 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | 1 | NM_001174147.2 | ENSP00000362573.3 | ||
LMX1B | ENST00000355497.10 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | 1 | ENSP00000347684.5 | |||
LMX1B | ENST00000526117.6 | c.691C>T | p.Arg231* | stop_gained | Exon 4 of 8 | 1 | ENSP00000436930.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This premature translational stop signal has been observed in individuals with clinical features of nail-patella syndrome (PMID: 9618165; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg231*) in the LMX1B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LMX1B are known to be pathogenic (PMID: 9590287, 15498463). This variant is also known as p.Arg208Ter. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 7006). -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18535845, 9618165, 25898926, 33692073) -
Inborn genetic diseases Pathogenic:1
The c.691C>T (p.R231*) alteration, located in exon 4 (coding exon 4) of the LMX1B gene, consists of a C to T substitution at nucleotide position 691. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 231. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. for nail patella syndrome; however, its clinical significance for LMX1B-related focal segmental glomerulosclerosisis is uncertain. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration, referred to as "Arg208Ter", was reported in a family with nail patella syndrome (Vollrath, 1998). Based on the available evidence, this alteration is classified as pathogenic. -
Nail-patella syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at